Absorption of milk-borne insulin-like growth factor-I into portal blood of suckling rats

Anthony F Philipps, B. Dvorak, P. J. Kling, J. G. Grille, O. Koldovsky

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background: Insulin-like growth factors (IGFs) are potent mitogens that have been implicated in control of growth and development during the perinatal period. These hormones are also present in biologically significant quantities in mammalian milks. Although one site of action of these IGFs may be at the intestinal level, current information about whether they pass intact into the circulation is conflicting. Methods: To test the hypothesis that milk-borne IGFs are absorbed into blood in receptor-active form, suckling rats were given either recombinant human (rh)125I-IGF-I or -II (4 x 106 counts per minute [cpm]), and the activity present in portal and cardiac blood was examined at 5, 10, 20, and 30 minutes after ingestion for presence of appropriate molecular weight peptides in these samples. In selected samples, purified radioactive samples were tested for their ability to bind competitively to crude membranes bearing IGF receptors. Results: The results of these studies indicate that rh125I-IGF-I is absorbed in receptor-active form into the portal circulation and that maximal amounts are present 20 to 30 minutes after ingestion. Estimation of the presence of intact hormone was made on the basis of the elution profile of samples when run on gel chromatography as well as reversed-phase high-performance liquid chromatography. Isolated samples from portal blood also bound competitively to placental membranes bearing IGF receptors. In contrast, rh125I-IGF-II could not be demonstrated in receptor-active form in portal blood. Chromatography showed appropriate sized peaks with greater activity in portal than cardiac samples, but competitive binding was not appreciated. Conclusions: It is likely that at least milk-borne IGF-I is absorbed intact and may exert effects on liver and other peripheral tissues. In addition, this study lends further credence to the possibility of an enterohepatic circulation for IGF-I. (C) 2000 Lippincott Williams and Wilkins, Inc.

Original languageEnglish (US)
Pages (from-to)128-135
Number of pages8
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume31
Issue numberSUPPL. 2
DOIs
StatePublished - 2000

Fingerprint

insulin-like growth factor I
Insulin-Like Growth Factor I
suckling
somatomedins
Milk
Somatomedins
Somatomedin Receptors
milk
rats
blood
receptors
Eating
Hormones
Enterohepatic Circulation
sampling
Insulin-Like Growth Factor II
Competitive Binding
Membranes
Reverse-Phase Chromatography
Growth and Development

Keywords

  • Insulin-like growth factor
  • Milk
  • Nutrition
  • Portal venous blood
  • Suckling

ASJC Scopus subject areas

  • Gastroenterology
  • Histology
  • Medicine (miscellaneous)
  • Food Science
  • Pediatrics, Perinatology, and Child Health

Cite this

Absorption of milk-borne insulin-like growth factor-I into portal blood of suckling rats. / Philipps, Anthony F; Dvorak, B.; Kling, P. J.; Grille, J. G.; Koldovsky, O.

In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 31, No. SUPPL. 2, 2000, p. 128-135.

Research output: Contribution to journalArticle

Philipps, Anthony F ; Dvorak, B. ; Kling, P. J. ; Grille, J. G. ; Koldovsky, O. / Absorption of milk-borne insulin-like growth factor-I into portal blood of suckling rats. In: Journal of Pediatric Gastroenterology and Nutrition. 2000 ; Vol. 31, No. SUPPL. 2. pp. 128-135.
@article{1ca525dd53614b2394023eebcd5c88f0,
title = "Absorption of milk-borne insulin-like growth factor-I into portal blood of suckling rats",
abstract = "Background: Insulin-like growth factors (IGFs) are potent mitogens that have been implicated in control of growth and development during the perinatal period. These hormones are also present in biologically significant quantities in mammalian milks. Although one site of action of these IGFs may be at the intestinal level, current information about whether they pass intact into the circulation is conflicting. Methods: To test the hypothesis that milk-borne IGFs are absorbed into blood in receptor-active form, suckling rats were given either recombinant human (rh)125I-IGF-I or -II (4 x 106 counts per minute [cpm]), and the activity present in portal and cardiac blood was examined at 5, 10, 20, and 30 minutes after ingestion for presence of appropriate molecular weight peptides in these samples. In selected samples, purified radioactive samples were tested for their ability to bind competitively to crude membranes bearing IGF receptors. Results: The results of these studies indicate that rh125I-IGF-I is absorbed in receptor-active form into the portal circulation and that maximal amounts are present 20 to 30 minutes after ingestion. Estimation of the presence of intact hormone was made on the basis of the elution profile of samples when run on gel chromatography as well as reversed-phase high-performance liquid chromatography. Isolated samples from portal blood also bound competitively to placental membranes bearing IGF receptors. In contrast, rh125I-IGF-II could not be demonstrated in receptor-active form in portal blood. Chromatography showed appropriate sized peaks with greater activity in portal than cardiac samples, but competitive binding was not appreciated. Conclusions: It is likely that at least milk-borne IGF-I is absorbed intact and may exert effects on liver and other peripheral tissues. In addition, this study lends further credence to the possibility of an enterohepatic circulation for IGF-I. (C) 2000 Lippincott Williams and Wilkins, Inc.",
keywords = "Insulin-like growth factor, Milk, Nutrition, Portal venous blood, Suckling",
author = "Philipps, {Anthony F} and B. Dvorak and Kling, {P. J.} and Grille, {J. G.} and O. Koldovsky",
year = "2000",
doi = "10.1097/00005176-200008000-00008",
language = "English (US)",
volume = "31",
pages = "128--135",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Absorption of milk-borne insulin-like growth factor-I into portal blood of suckling rats

AU - Philipps, Anthony F

AU - Dvorak, B.

AU - Kling, P. J.

AU - Grille, J. G.

AU - Koldovsky, O.

PY - 2000

Y1 - 2000

N2 - Background: Insulin-like growth factors (IGFs) are potent mitogens that have been implicated in control of growth and development during the perinatal period. These hormones are also present in biologically significant quantities in mammalian milks. Although one site of action of these IGFs may be at the intestinal level, current information about whether they pass intact into the circulation is conflicting. Methods: To test the hypothesis that milk-borne IGFs are absorbed into blood in receptor-active form, suckling rats were given either recombinant human (rh)125I-IGF-I or -II (4 x 106 counts per minute [cpm]), and the activity present in portal and cardiac blood was examined at 5, 10, 20, and 30 minutes after ingestion for presence of appropriate molecular weight peptides in these samples. In selected samples, purified radioactive samples were tested for their ability to bind competitively to crude membranes bearing IGF receptors. Results: The results of these studies indicate that rh125I-IGF-I is absorbed in receptor-active form into the portal circulation and that maximal amounts are present 20 to 30 minutes after ingestion. Estimation of the presence of intact hormone was made on the basis of the elution profile of samples when run on gel chromatography as well as reversed-phase high-performance liquid chromatography. Isolated samples from portal blood also bound competitively to placental membranes bearing IGF receptors. In contrast, rh125I-IGF-II could not be demonstrated in receptor-active form in portal blood. Chromatography showed appropriate sized peaks with greater activity in portal than cardiac samples, but competitive binding was not appreciated. Conclusions: It is likely that at least milk-borne IGF-I is absorbed intact and may exert effects on liver and other peripheral tissues. In addition, this study lends further credence to the possibility of an enterohepatic circulation for IGF-I. (C) 2000 Lippincott Williams and Wilkins, Inc.

AB - Background: Insulin-like growth factors (IGFs) are potent mitogens that have been implicated in control of growth and development during the perinatal period. These hormones are also present in biologically significant quantities in mammalian milks. Although one site of action of these IGFs may be at the intestinal level, current information about whether they pass intact into the circulation is conflicting. Methods: To test the hypothesis that milk-borne IGFs are absorbed into blood in receptor-active form, suckling rats were given either recombinant human (rh)125I-IGF-I or -II (4 x 106 counts per minute [cpm]), and the activity present in portal and cardiac blood was examined at 5, 10, 20, and 30 minutes after ingestion for presence of appropriate molecular weight peptides in these samples. In selected samples, purified radioactive samples were tested for their ability to bind competitively to crude membranes bearing IGF receptors. Results: The results of these studies indicate that rh125I-IGF-I is absorbed in receptor-active form into the portal circulation and that maximal amounts are present 20 to 30 minutes after ingestion. Estimation of the presence of intact hormone was made on the basis of the elution profile of samples when run on gel chromatography as well as reversed-phase high-performance liquid chromatography. Isolated samples from portal blood also bound competitively to placental membranes bearing IGF receptors. In contrast, rh125I-IGF-II could not be demonstrated in receptor-active form in portal blood. Chromatography showed appropriate sized peaks with greater activity in portal than cardiac samples, but competitive binding was not appreciated. Conclusions: It is likely that at least milk-borne IGF-I is absorbed intact and may exert effects on liver and other peripheral tissues. In addition, this study lends further credence to the possibility of an enterohepatic circulation for IGF-I. (C) 2000 Lippincott Williams and Wilkins, Inc.

KW - Insulin-like growth factor

KW - Milk

KW - Nutrition

KW - Portal venous blood

KW - Suckling

UR - http://www.scopus.com/inward/record.url?scp=0039334748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0039334748&partnerID=8YFLogxK

U2 - 10.1097/00005176-200008000-00008

DO - 10.1097/00005176-200008000-00008

M3 - Article

C2 - 10941963

AN - SCOPUS:0039334748

VL - 31

SP - 128

EP - 135

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - SUPPL. 2

ER -